BIM
115.5
+1.49%↑
SRT3
228.3
-0.7%↓
GXI
55.3
+2.88%↑
ICAD
21.08
-0.57%↓
BIM
115.5
+1.49%↑
SRT3
228.3
-0.7%↓
GXI
55.3
+2.88%↑
ICAD
21.08
-0.57%↓
BIM
115.5
+1.49%↑
SRT3
228.3
-0.7%↓
GXI
55.3
+2.88%↑
ICAD
21.08
-0.57%↓
BIM
115.5
+1.49%↑
SRT3
228.3
-0.7%↓
GXI
55.3
+2.88%↑
ICAD
21.08
-0.57%↓
BIM
115.5
+1.49%↑
SRT3
228.3
-0.7%↓
GXI
55.3
+2.88%↑
ICAD
21.08
-0.57%↓
24h
Curent
Minim
119.7
Maxim
122.55
Venit | -142M 667M |
---|---|
Vânzări | 152M 5.4B |
P/E Medie Sector | 26.27 57.333 |
EPS | 2.2 |
Randament dividend | 1.34 |
Marjă de profit | 12.311 |
EBITDA | 85M 1.6B |
Recomandări | Cumpărare |
---|---|
Prognoză pe 12 luni | +38.83% upside |
Randament dividend Medie Sector | 1.34% 2.63% |
---|---|
Următoarele câștiguri | 15 mai 2025 |
Capitalizare de piață | 33B 98B |
---|---|
Deschiderea anterioară | 119.98 |
Închiderea anterioară | 121.4 |
By Trading Central
Încredere
Very Strong Bullish Evidence
117.55 / 120.4 Suport & Rezistență
Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.
6 mar. 2025, 06:27 UTC
Merck KGaA Forecasts Earnings, Sales Growth After In-Line Results
DJ
Citește
11 feb. 2025, 07:03 UTC
Germany's Merck in Talks to Buy SpringWorks Therapeutics
DJ
Citește
10 feb. 2025, 16:38 UTC
SpringWorks Therapeutics Shares Rise on Report it May be Acquired
DJ
Citește
24 apr. 2025, 22:51 UTC
Germany's Merck Nears Roughly $3.5 Billion Deal for SpringWorks -- Update
DJ
Citește
24 apr. 2025, 20:54 UTC
Merck KGaA: No Final Decision Has Been Taken; No Legally Binding Agreement Has Been Entered Into
DJ
Citește
24 apr. 2025, 20:50 UTC
Merck KGaA Confirms Late-Stage Discussions With SpringWorks Therapeutics on Potential Acquisition for About 47c a Share
DJ
Citește
24 apr. 2025, 19:05 UTC
Merck KGaA Expected to Pay Close to $47 a Share for SpringWorks, Sources Say -- WSJ
DJ
Citește
24 apr. 2025, 19:05 UTC
Merck KGaA, SpringWorks Deal Expected to Be Finalized as Soon as Monday, Sources Say -- WSJ
DJ
Citește
24 apr. 2025, 19:05 UTC
Germany's Merck Nears Roughly $3.5 Billion Deal for SpringWorks -- WSJ
DJ
Citește
24 apr. 2025, 19:05 UTC
Merck KGaA Nears Roughly $3.5 Billion Takeover of SpringWorks Therapeutics, Sources Say -- WSJ
DJ
Citește
6 mar. 2025, 11:18 UTC
Impact from U.S. Tariffs Is Manageable for Merck KGaA, CEO Says -- Market Talk
DJ
Citește
6 mar. 2025, 11:14 UTC
Merck KGaA's Outlook Signals Greater Transparency -- Market Talk
DJ
Citește
6 mar. 2025, 08:20 UTC
Merck KGaA's Earnings Guidance Seems Soft Amid Semiconductor Uncertainty -- Market Talk
DJ
Citește
6 mar. 2025, 06:00 UTC
Merck KGaA Expects 2025 Net Sales Between EUR21.5B and EUR22.9B
DJ
Citește
6 mar. 2025, 06:00 UTC
Merck KGaA 2024 Adj EPS EUR8.63
DJ
Citește
6 mar. 2025, 06:00 UTC
Merck KGaA Expects 2025 EBITDA Before One-Time Items Between EUR6.1B and EUR6.6B
DJ
Citește
6 mar. 2025, 06:00 UTC
Merck KGaA 2024 EBIT EUR3.645B
DJ
Citește
6 mar. 2025, 06:00 UTC
Merck KGaA 2024 After-Tax Profit EUR2.79B
DJ
Citește
6 mar. 2025, 06:00 UTC
Merck KGaA 2024 Ebitda Before One-Time Items EUR6.07B
DJ
Citește
6 mar. 2025, 06:00 UTC
Merck KGaA 2024 EBITDA EUR5.78B
DJ
Citește
6 mar. 2025, 06:00 UTC
Merck KGaA 2024 Sales EUR21.16B
DJ
Citește
6 mar. 2025, 06:00 UTC
Merck KGaA Keeps Dividend at EUR2.20
DJ
Citește
6 mar. 2025, 06:00 UTC
Analysts Saw Merck KGaA 2024 Sales at EUR21.14B
DJ
Citește
6 mar. 2025, 06:00 UTC
Analysts Saw Merck KGaA 2024 Ebitda Before One-Time Items at EUR6.08B
DJ
Citește
11 feb. 2025, 16:45 UTC
Merck's Potential Springworks Deal Unlikely to Move Needle on Earnings -- Market Talk
DJ
Citește
11 feb. 2025, 10:54 UTC
Germany's Merck Potential Buy of SpringWorks Therapeutics Puts Its Strategy Into Question -- Market Talk
DJ
Citește
11 feb. 2025, 10:52 UTC
German Merck's Potential Buy of SpringWorks Therapeutics Holds Profitability Risk -- Market Talk
DJ
Citește
6 ian. 2025, 13:08 UTC
Merck KGaA: Transaction closed on Dec. 23, 2024
DJ
Citește
6 ian. 2025, 13:07 UTC
Merck KGaA: Didn't Disclose Financial Details
DJ
Citește
6 ian. 2025, 13:06 UTC
Merck KGaA: HUB's Organoid Offering Complements Merck KGaA's Cell Culture Portfolio
DJ
Citește
Modificare preț
By TipRanks
Prognoză pe 12 luni
Medie 166.25 EUR 38.83%
Maxim 190 EUR
Minim 107 EUR
În baza a 9 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruMerck KGaA - Dist în ultimele 3 luni.
By TipRanks
Cumpărare
9 ratings
6
Cumpărare
2
Păstrare
1
Vânzare
Ținând cont de 9 analiști care au acordat evaluări ale acțiunilor Merck KGaA - Dist în ultimele 3 luni.
By Trading Central
Termen scurt
Very Strong Bullish Evidence
Recent bullish events outweigh bearish events.
Termen mediu
Bearish Evidence
All events are bearish.
Termen lung
Bearish Evidence
All events are bearish.
Cheltuieli de vânzare și administrare
Cheltuieli de exploatare
Profit pre-impozitare
Vânzări
Costul vânzărilor
Profit brut din vânzări
Cheltuieli cu dobânzile pe datorie
EBITDA
Profit operațional
$